Preprint Review Version 1 This version is not peer-reviewed

Exploring the Next Generation of Metformin Derivatives and Their Biomedical Promise

Version 1 : Received: 1 October 2024 / Approved: 1 October 2024 / Online: 2 October 2024 (08:05:19 CEST)

How to cite: Žídek, Š.; Štěpánková, K.; Lehocky, M. Exploring the Next Generation of Metformin Derivatives and Their Biomedical Promise. Preprints 2024, 2024100086. https://doi.org/10.20944/preprints202410.0086.v1 Žídek, Š.; Štěpánková, K.; Lehocky, M. Exploring the Next Generation of Metformin Derivatives and Their Biomedical Promise. Preprints 2024, 2024100086. https://doi.org/10.20944/preprints202410.0086.v1

Abstract

Metformin is a drug recommended as the first-line agent for the treatment of patients with type 2 diabetes mellitus due to its high efficiency and good safety profile. Additionally, literature has described its favourable effect in treating several other diagnoses. This review aims to summarize recent research on metformin modification and derivatization, which has led to agents with higher efficiency or expanded the application possibilities of metformin. Namely, buformin, phenformin, imeglimin, lixumistat, IM176 derivatives, moroxydine, proguanil, cycloguanil, metformin sulfenamides and sulphonamides, polypeptide derivative LysMET, artesinate-metformin conjugate AM2. Additionally, salts such as metformin hydrochloride, metformin hydrobromide, metformin hydroiodide, metformin acetate, metformin embonate, metformin threonate, metformin tartrate, metformin citrate, metformin mesylate and metformin maleate. The goal is to highlight recent research efforts and introduce perspectives for novel and effective biomedical substances within the still unexplored field.

Keywords

metformin; biguanide; metformin derivatives; structural modification; medicinal chemistry; diabetes mellitus

Subject

Medicine and Pharmacology, Pharmacology and Toxicology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.